Please assess the completion status of the following clinical trial:

Trial Title: Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion criteria:~* History of PONV and/or motion sickness.~* Have not smoked for the last 6 months.~* Having certain types of abdominal, breast or shoulder surgeries.~Exclusion criteria:~* Pregnant or breastfeeding.~* Taking certain medications.~* Have certain pre-existing medical conditions.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Arm 1 (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).